Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Plasma Darman Sarve Sepid botulinum toxin type A with Dysport in treatment of glabellar lines
IRCT20101012004920N11Phase 3Completed
- Sponsor
- Plasma Darman Sarve Sepid
- Start
- Apr 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in glabellar furrowing (2 arms), sponsored by Plasma Darman Sarve Sepid. Started Apr 2025; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on IRCT20101012004920N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101012004920N11.